James Engelhart, Chief Financial Officer at Biohaven Pharmaceutical Holding Co Ltd. (BHVN), sold 21,600 shares at $26.26 ($577K) on 2017-11-09, disclosed to the SEC on 2017-11-14.
Open-market sale of $577k BHVN by Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $26.26 | 13,083 | $344K | 59.6% |
| 2 | $27.37 | 8,517 | $233K | 40.4% |
| Total | $26.70 avg | 21,600 | $577K | 100% |
| Filing → |
| BHVN | BUY | 2019-06-28 | $108K | — | Filing → |
| BHVN | SELL | 2018-05-30 | $175K | — | Filing → |
| BHVN | SELL | 2018-05-09 | $69K | — | Filing → |